Cannabis Law Report

DECEMBER 3, 2021

We are honored to be at the AES Meeting this year after almost a year of planning from our medical and scientific affairs, clinical, and advocacy teams, with nine presentations spanning our IV and oral portfolio—Marinus’ largest data showing to date,” said Scott Braunstein, M.D., Chief Executive Officer of Marinus Pharmaceuticals. “We

Epilepsy 52

Epilepsy Pharmaceutical Data Clinical Trials 52

Cannabis Law Report

SEPTEMBER 9, 2021

WHAT: During the session, “ Cannabis Moves Toward the Mainstream ,” Nielsen will share IRI and BDSA’s predictions for mainstream market opportunities, cannabis ingredients, product development, labeling and safety. . . WHEN: Cross Channel Measurement in a Time of Data Collection Challenges. . 20, 2021, from 2:40 – 2:55 p.m.

Events 102

Events Wellness and Beauty Data Media 102

Cannabis Law Report

JUNE 23, 2021

Sapphire Medical Clinics presented six abstracts focused on the latest research on cannabinoids based on data from the UK Medical Cannabis Registry during the 31st Annual International Cannabinoid Research Society Symposium on the Cannabinoids (ICRS2021). PROGRAMME.and.ABSTRACTS. Patient-reported outcomes. Improved quality of life.

Cannabinoids 59

Cannabinoids Data Chronic Pain Sleep 59

Cannabis Law Report

FEBRUARY 24, 2022

A major observation describes a situation that may result in a risk to public health or public safety, or may involve fraud, or may increase the risk of diversion, prevent the detection of diversion or health risk. Health Canada may take enforcement actions to address non-compliance or to mitigate risks to public health or public safety.

Compliance 52

Compliance Compliance Data Safety 52

Illinois News Joint

JANUARY 5, 2024

The GPS tracking system shall also be able to store historic data (for no less than 12months) and shall permit the Department to search all real-time and archived data upon request. To find cannabis-friendly events in Illinois, visit here. Transporters are subject to random inspections by the Department, DPH, and ISP.

Compliance 70

Compliance Compliance Agriculture Policy 70

Cannabis Law Report

JANUARY 27, 2020

We take a look at where CBD regulation might be going and whether we should be concerned about safety writes Rob Verkerk PhD, scientific and executive director, ANH-Intl. We take a look at where CBD regulation might be going and whether we should be concerned about safety. A new ‘problem’: safety. ? A new ‘problem’: safety.

Safety 59

Safety CBD Food Seed-To-Sale 59

Cannabis Law Report

JUNE 1, 2021

The initial shipment is designated to be used by the Clinic in a pilot run in preparation for the previously announced study , based out of the United Kingdom, on the safety and efficacy of cannabis and hemp for the treatment of patients suffering from chronic pain. About RYAH Group, Inc. RYAH Group, Inc.

Clinical Trials 89

Clinical Trials Chronic Pain Data Research and Development 89

Cannabis Law Report

SEPTEMBER 15, 2021

The FDA has received adverse event reports involving delta-8 THC-containing products. Of the 22 patients, 19 experienced adverse events after ingesting delta-8 THC-containing food products (e.g., Adverse events included vomiting, hallucinations, trouble standing, and loss of consciousness. brownies, gummies).

THC 105

THC Pets Events Hemp 105

The Joint Blog

APRIL 17, 2020

This study summarizes potential adverse drug events related to THC when combined with other medications Medicinal Use of Marijuana Cannabis has been used widely across North America in various state or provincial medical marijuana programs. However, in some cases, the risks may outweigh even the proven benefits.

Events 48

Events THC Chronic Pain Sleep 48

Cannabis Law Report

JUNE 16, 2021

This engagement will build on the strong foundation on Santé, having treated more than 10,000 patients since 2014 under a real-world data protocol. Training will be provided within the research program for licensed practitioners to assess the safety of psychedelic medicines and to classify and report positive and adverse events.

Clinical Trials 104

Clinical Trials Therapy Research and Development Events 104

Cannabis Law Report

MAY 23, 2022

Hemp Roundtable is now asking FDA to take these same actions for dietary supplements that contain legal hemp-derived cannabidiol (CBD) and other lawful hemp ingredients, especially in light of new safety data on CBD. “We

Policy 52

Policy Hemp CBD Safety 52

Veriheal

MAY 30, 2023

Cancer Pain Relief With Cannabis: What the New Study Shows Utilizing data from the Quebec Cannabis Registry in Canada, researchers sought to examine the safety and effectiveness of cannabis in addressing cancer pain. This research involved monitoring the treatment responses of 358 adult cancer patients over 3.5 Interestingly, 72.5%

Medicine 96

Medicine Treatment Patients Data 96

Cannabis Law Report

AUGUST 30, 2021

I’m excited to join the Travelers Institute for a data-driven discussion,” said Wasserman. With new census data, control of Congress on a knife-edge and redistricting just ahead, there couldn’t be a better time to dive into the numbers.”. redistricting efforts and what those trends might mean for future elections. 22 – “High Risk?

Programs 105

Programs Data Policy Topical 105

Veriheal

JUNE 30, 2023

To start, participants reported that psilocybin had helped them process emotions tied to painful events in their past. The 14-page document covers several aspects of the drug development process, including trial best practices, data collection, and new drug application requirements.

Clinical Trials 92

Clinical Trials Research and Development Therapy Policy 92

Cannabis Law Report

AUGUST 27, 2021

The Board will advise Delic and its subsidiaries, including Ketamine Infusion Centers, Delic Labs and others, as they develop safety protocols and best practices pertaining to legal psychedelic wellness treatments today and those legalized in the future.

Research and Development 98

Research and Development Treatment Media Medicine 98

Cannabis Law Report

MARCH 17, 2022

Data Manager. The Data Manager, under the direction of the Director of Data Analytics, will be responsible for managing, manipulating, analyzing, and modeling data to support the Commission’s research agenda, licensing, and compliance decisions. Deadline to apply: March 31, 2022 by 5:00 p.m.

Compliance 52

Compliance Compliance Research and Development Data 52

Cannabis Law Report

JULY 29, 2021

With patients at the core of what we do, Tetra Bio-Pharma is focused on providing rigorous scientific validation and safety data required for inclusion into the existing biopharma industry by regulators, physicians and insurance companies. For more information visit: www.tetrabiopharma.com. Forward-looking statements.

Research and Development 105

Research and Development Clinical Trials Events Cannabinoids 105

TheAnswerPage

MAY 16, 2021

According to one study involving 96 cancer patients receiving supportive cancer care, the data support the safety and effectiveness of medical marijuana as a complementary option for improving pain control, appetite and quality of life for cancer patients.

Safety 52

Safety Data Patients Events 52

Cannabis Law Report

JANUARY 12, 2022

As Oregon prepares to roll out the nation’s first legal psilocybin-assisted services program, there is a recognized need for the community to track adverse events and measure efficacy. We don’t believe safety and access are opposing polarities that must be constantly balanced.

Research and Development 52

Research and Development Therapy Safety Clinical Trials 52

Cannabis Law Report

NOVEMBER 24, 2019

Building the bridge between brands and the marketplace through testing and the importance of good data. These events, amongst other drivers, have shown the obvious need to regulate product safety in CBD and THC products in a holistic and standardized way.

Business 95

Business Data Wellness and Beauty Safety 95

TheAnswerPage

DECEMBER 5, 2020

According to one study involving 96 cancer patients receiving supportive cancer care, the data support the safety and effectiveness of medical marijuana as a complementary option for improving pain control, appetite and quality of life for cancer patients.

Data 52

Data Safety Patients Events 52

TheAnswerPage

JUNE 27, 2020

According to one study involving 96 cancer patients receiving supportive cancer care, the data support the safety and effectiveness of medical marijuana as a complementary option for improving pain control, appetite and quality of life for cancer patients.

Data 52

Data Safety Patients Events 52

Cannabis Law Report

OCTOBER 22, 2021

–The Company expects to hold a Research & Development event to review,these breakthrough findings in Q4 2021 that will be open to the public, shareholders, analysts and the media– TORONTO, CANADA – October 19, 2021 – Cybin Inc.

Research and Development 52

Research and Development Safety Media Data 52

Cannabis Law Report

JULY 28, 2021

Collaborating with County departments, community leaders and other agencies to obtain data, provide analysis and convey results that support the Supervisor’s policy agenda. Recommend and develop more effective strategies to address policy priorities based on research, data and stakeholder buy-in. Skills And Experience Required.

Policy 105

Policy Legislation Research and Development Data 105

Veriheal

JUNE 1, 2023

These research submissions may have left regulators skeptical about the safety of this relatively affordable, highly productive herb for livestock. The letter cautioned that there are no substantial data on the residual concentration of cannabinoids in animals fed with hemp products.

THC 87

THC Hemp CBD Supply Chain 87

Cannabis Law Report

AUGUST 17, 2021

(Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced topline data from its open-label Phase 2 trial evaluating safety and efficacy of adjunctive oral ganaxolone treatment in 23 patients with seizures associated with tuberous sclerosis complex (TSC).

Pharmaceutical 98

Pharmaceutical Clinical Trials Treatment Patients 98

Cannabis Law Report

FEBRUARY 3, 2022

The Smart Event, comprising in-person and online platforms, to convene thousands of engineers, business leaders, disruptive companies, and innovative thinkers to design powerful solutions to today’s most pressing challenges. ANAHEIM, Calif.–(BUSINESS The online platform will open on March 14 and is accessible to all registered visitors.

Packaging 52

Packaging Events Education Supply Chain 52

Cannabis Law Report

SEPTEMBER 23, 2021

The major concerns noted were adverse events following consumption (many from inadvertent intoxication), marketing to and use by minors, and the potential presence of harmful by-products and unsafe manufacturing practices. The FDA has received adverse event reports involving delta-8 THC-containing products. CDC Health Alert.

THC 52

THC Concentrates Pets DEA 52

Cannabis Law Report

JUNE 16, 2021

Genetic Screening Platform Technology and Data to Strengthen Entheon’s Psychedelic-Assisted Protocols. Lobo brings a highly experienced and specialized team of technology experts in the fields of genetics, diagnostics, data and analytics, as well as a fully operational 5,000 sq. Vancouver, British Columbia–(Newsfile Corp.

Research and Development 105

Research and Development Data Conditions Events 105

Cannabis Law Report

JANUARY 12, 2022

In accordance with FDA requirements, an independent panel of qualified experts reviewed HempFusion’s safety dossier on its hemp-derived CBD extract, which included safety and toxicology studies, the published results of these studies, and a comprehensive review of the scientific literature on CBD. HempFusion Wellness Inc.

Retail 52

Retail CBD Extraction Research and Development 52

Cannabis Law Report

OCTOBER 6, 2021

Flora Pharma will seek to identify scientific gaps in the cannabis industry and ultimately work to translate that to pharmaceutical cannabis products backed by data. Flora Pharma expects to fast track traditional FDA and NHS timelines by running phase trials in parallel (in vitro, in vivo, pilot in human, safety/efficacy, etc.).

Clinical Trials 52

Clinical Trials Research and Development Pharmaceutical Events 52

Cannabis Law Report

NOVEMBER 4, 2021

Hybrid Event Pairs In-Person Trade Show with Virtual Offerings through SupplySide Network 365 to Provide Opportunities for Innovation Professionals to Do Business. SupplySide Network 365 brought exciting advances and created new ways for industry members at the event and remote to connect and engage with show content.

Food 40

Food Events Supply Chain Business 40

Cannabis Law Report

AUGUST 27, 2021

Built on a foundation of regulatory compliance and human safety, HempFusion Wellness offers a diverse product portfolio comprising of over 75 SKUs including tinctures, proprietary FDA Drug Listed Over-The-Counter (OTC) Topicals, Doctor/Practitioner Lines and more. HempFusion Wellness Inc. Follow HempFusion on Twitter , Facebook and Instagram.

Research and Development 105

Research and Development Events Hemp Food 105

Puff Puff Post

MARCH 10, 2020

” Study 755-101-HV is a randomized, vehicle controlled, double-blind, Phase 1 trial, examining the safety and tolerability of two strengths of INM-755 cream in 22 healthy adult volunteers over a 14-day treatment period as part of a randomized, vehicle controlled, double-blind, Phase 1 trial.

Clinical Trials 84

Clinical Trials Pharmaceutical Research and Development Cannabinoids 84

The Joint Blog

JANUARY 3, 2020

” This study was designed “to further investigate efficacy and safety of CBM in GTS and specifically compare effects of different CBM.” ” All these patients were asked to complete an online survey (second study part) to receive more detailed data about treatment with CBM. .”

Data 49

Data Treatment Marijuana Patients 49

Cannabis Law Report

FEBRUARY 20, 2022

Domestic carriers are staying away from the industry because of the immaturity of the market, but also because of a lack of data integrity and the stigma around the product. And securing product recall insurance and general liability go a long way toward protecting cannabis companies from risk in the event of a major loss.

Edibles 118

Edibles Hydroponic Retail Cannabis 118

Cannabis Law Report

JUNE 16, 2019

As the district attorneys for Albany County and Manhattan, it is our duty to uphold justice and public safety on behalf of our upstate and downstate communities. Cuomo and state legislators must correct staggering inequities and promote public safety by passing the Marijuana Revenue and Taxation Act. In the final days of session, Gov.

Legalization 55

Legalization Safety Legislation Decriminalization 55